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Culture-induced changes in mRNA 
expression levels of efflux and SLC-transporters 
in brain endothelial cells
C. Goldeman, B. Ozgür and B. Brodin*
Abstract 
Background: The complexity of the neurovascular unit (NVU) poses a challenge in the investigations of drug trans-
port across the blood–brain barrier (BBB) and the function of the brain capillary endothelium. Several in vitro models 
of the brain capillary endothelium have been developed. In vitro culture of primary endothelial cells has, however, 
been reported to alter the expression levels of various brain endothelial proteins. Only a limited number of studies 
have addressed this in detail. The aim of the present study was to investigate mRNA levels of selected BBB transport-
ers and markers in in vitro models of the BBB based on bovine primary endothelial cells and compare these to the 
levels estimated in freshly isolated bovine brain capillaries.
Methods: Brain capillaries were isolated from bovine cerebral cortex grey matter. Capillaries were seeded in culture 
flasks and endothelial cells were obtained using a brief trypsinization. They were seeded onto permeable supports 
and cultured in mono-, non-contact- or contact co-culture with/without primary rat astrocytes. mRNA-expression 
levels of the selected BBB markers and transporters were evaluated using qPCR and monolayer integrity of resulting 
monolayers was evaluated by measuring the transendothelial electrical resistance (TEER).
Results: The capillary mRNA transcript profile indicated low expression of ABCC1 and CLDN1. The mRNA expression 
levels of TPA, OCLN, ABCB1, SLC2A1, SLC16A1 and SLC7A5 were significantly decreased in all culture configurations com-
pared to freshly isolated bovine brain capillaries. ALP, VWF, ABCC1 and ABCC4 were upregulated during culture, while 
the mRNA expression levels of F11R, TJP1, CLDN5, CLDN1 and ABCG2 were found to be unaltered. The mRNA expres-
sion levels of VWF, ALP, ABCB1 and ABCC1 were affected by the presence of rat astrocytes.
Conclusion: The endothelial mRNA transcript profile in bovine capillaries obtained in this study correlated nicely 
with profiles reported in mice and humans. Cultured endothelial cells drastically downregulated the mRNA expression 
of the investigated SLC transporters but maintained expression of efflux transporter and junctional protein mRNA, 
implying that the bovine in vitro BBB models may serve well to investigate basic barrier biology and in vivo permea-
tion of passively permeating compounds and efflux transporter substrates but may be less well suited for investiga-
tions of SLC-mediated transport.
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Introduction
The endothelium of the small brain capillaries makes up 
the blood–brain barrier (BBB). Together with pericytes 
and astrocytic end-feets, they serve as a restrictive bar-
rier for passage of a wide range of structurally diverse 
compounds, including most drug compounds. This 
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function is due to the presence of tight junctions (TJs) 
between the adjacent endothelial cells, efflux transporters 
and metabolizing enzymes (for references, see [1]). The 
trans-endothelial transport of nutrients and micronutri-
ents occurs via uptake transporters (solute carriers) and 
receptors, that are highly regulated.
Several in vitro models of the BBB with brain capillary 
endothelial cells grown on permeable supports have been 
developed. These models are widely used to investigate 
drug transport mechanisms across the BBB, predict CNS 
drug exposure and to investigate interactions between 
the cell types of the neurovascular unit (NVU) [6, 18, 
21]. Attempts of developing in  vitro models of the BBB 
have included the use of immortalized cell lines from ani-
mal or human origin, primary endothelial cells isolated 
from animal sources (e.g. murine, bovine or porcine) and 
recently, human induced pluripotent stem cells that have 
been differentiated towards a brain endothelial pheno-
type [17, 22, 23, 35]. In general, immortalized cell lines 
tend to express a wide range of endothelial marker pro-
teins, but they do, however, exhibit low expression of TJ 
proteins, resulting in cell culture models with low barrier 
integrity [15]. In vitro BBB models based on isolated pri-
mary cells retain many important properties of the BBB 
by expressing BBB-specific marker proteins, TJ proteins, 
receptor systems and efflux transporters upon cultiva-
tion on permeable supports. There are, however, reports 
of suboptimal expression of transport proteins, especially 
of the solute carrier (SLC) family, as recently reviewed 
by Helms et al. [15]. In the present study, we investigated 
mRNA levels of selected marker proteins from cultured 
bovine capillary endothelial cells, and compared those to 
the mRNA levels in freshly isolated brain capillaries in 
order to probe the effect of in vitro culture. We further-
more investigated whether important BBB marker genes, 
efflux pumps/ABC transporters and transport proteins of 
the SLC family were differentially expressed in brain cap-
illary endothelial cells cultured as monocultures (MC), 
non-contact co-culture (NCC) and contact co-culture 
(CCC) with isolated primary rat astrocytes.
We observed that expression levels of efflux trans-
porters were affected by in  vitro culture. ABCB1 was 
downregulated in all culture configurations, whereas 
ABCC1 and ABCC4 showed elevated expression levels 
compared to bovine capillaries. The expression level of 
ABCG2 was not altered. Furthermore, we observed a sig-
nificant decrease in expression levels of SLC transport-
ers, as SLC2A1, SLC7A5 and SLC16A1 were significantly 
downregulated in all culture configurations compared 
to bovine capillaries. TJ protein expression levels were 
not markedly affected, except for OCLN which was sig-
nificantly downregulated in MC and NCC, compared to 
capillaries.
Materials and methods
All materials were obtained from Sigma-Aldrich unless 
otherwise stated.
Isolation of primary bovine capillaries and rat astrocytes
Bovine brain tissue was obtained from a local abattoir 
(Mogens Nielsen kreaturslagteri A/S, Herlufmagle, Den-
mark). The isolation of bovine brain capillaries was per-
formed using a previously described method [16]. Briefly, 
the leptomeninges were removed and the grey matter 
was collected in Dulbecco’s Modified Eagle’s Medium 
(DMEM) and homogenized. The homogenate was fil-
tered through a 160 µm nylon net filter to collect capil-
lary fragments. The collected capillary fragments were 
centrifuged for 5 min at 500×g and the pellet was resus-
pended in DMEM supplemented with 10% fetal bovine 
serum (FBS), 10  ml/L MEM non-essential amino acids 
(NEAA) (×100), 100 U/mL–100  µg/mL pencillin-strep-
tomycin, 125  µg/mL heparin (DMEM-Comp) and the 
centrifugation was repeated. Pellets were resuspended in 
digestive enzyme mix containing 2000 U/mL Collagenase 
III, 3400 U/mL DNAse I and 900 U/mL Trypsin TRL in 
DMEM-Comp for 1 h at 37 °C in a water bath followed by 
filtration through a 200 µm nylon net filter. After centrif-
ugation for 5 min at 500×g, the pellets were resuspended 
in cryo-preservation media consisting of 1:9 DMSO: FBS 
and cryopreserved for later use. To isolate whole capillar-
ies for the analysis of capillary mRNA expression levels, 
capillaries were collected before the addition of digestive 
enzymes. The capillaries were spun down in 16% dextran 
 (Mr: 450,000–650,000) in DMEM at 2630×g for 15 min, 
followed by an additional 10 min spin at 485×g.
Primary rat astrocytes were isolated from 6  days old 
Sprague–Dawley rat pups, as previously described [20]. 
Pups were euthanized, and the cerebral cortex removed, 
followed by a gentle homogenization where the tissue was 
pressed through 80 µm nylon mesh into astrocyte media 
DMEM-I + 20% serum, consisting of DMEM-AQ, 1% 
(v/v) MEM NEAA (×100), 100 U/mL: 100 μg/ml penicil-
lin: streptomycin solution, 2.0  mM  l-Glutamine (Sigma 
G7513) and 20% FBS. The homogenate was then tritu-
rated using a steel canula (13 G + 5″). The cell suspension 
was plated in un-coated T75 culture flasks and cells were 
cultured for 4 weeks (37 °C, 5%  CO2). Media was changed 
two times a week, where Ast-DMEM I + 20% serum was 
used in the first week, Ast-DMEM I + 15% serum in the 
second week, and AST-DMEM II + 10% Serum (consist-
ing of Ast-DMEM I, 0.25 mM dBcAMP and 10% FBS) in 
the remaining 2  weeks. The aspirated medium was col-
lected as during the last 2 weeks of culture. This medium, 
which was named “astrocyte-conditioned medium” 
(ACM) was later used during culture of bovine brain cap-
illaries. Astrocytes were dissociated using trypsin–EDTA 
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and resuspended in 9:1 FBS: DMSO and cryopreserved 
until use. Isolated astrocytes were characterized by 
immunostaining for Glial fibrillary acidic protein (GFAP) 
and Filamentous-actin to ensure expression of GFAP and 
a star-shaped morphology, respectively (data not shown).
Endothelial cell culture
Primary bovine endothelial cells were used after one pas-
sage in three different culture configurations in mono 
culture (MC) and in co-culture with rat astrocytes either 
as non-contact or co-contact as previously described [16, 
18]. Briefly, frozen primary bovine brain capillaries were 
seeded onto T75 flasks coated with collagen type IV and 
fibronectin, and cultured in DMEM-Comp + ACM (1:1) 
for 4  days followed by a trypsinization of the resulting 
endothelial cells. The cells were subsequently seeded on 
permeable supports at a seeding density of 90,000 cells/
cm2 and cultured in either mono-, non-contact- or con-
tact- co-culture configurations. Co-culture models were 
prepared by seeding astrocytes on the bottom of the per-
meable support or directly into the trays at seeding den-
sity of 120,000 cells/well, 2 days prior to endothelial cell 
seeding. Cells were then cultured for 3 days in DMEM-
Comp. mixed with ACM at a ratio of 1:1 (MC) or DMEM-
Comp (NCC and CCC). After 3 days, the medium was 
changed to differentiation medium containing DMEM 
supplemented with 312.5  µM 8-(4-CPT)-cyclic adeno-
sine monophosphate, 0.5  µM dexamethasone, 17.5  µM 
RO-20-1724 and 50 mM N-[tris(hydroxymethyl)methyl]-
2-aminoethanesulfonic acid. The cells were cultured for 
additional 3  days. All trans endothelial electrical resist-
ance (TEER) measurements were performed on the 
experimental day after 6  days of culture on permeable 
supports with an Endohm Chamber connected to an 
 Evom2 Meter (WPI, Friedberg, Germany) to verify the 
presence of a barrier and was accepted if a TEER value of 
500 Ω*cm2 or above was obtained.
mRNA isolation and cDNA synthesis
mRNA from bovine capillaries was obtained by lysing 
the capillaries in TriZOL, according to the manufac-
turer’s instructions. mRNA from endothelial cells grown 
on permeable supports was isolated by using the GenEl-
ute™ Universal Total RNA Purification Kit (A4B0208) or 
 Nucleospin® RNA/Protein kit (Macherey–Nagel, Düren, 
Germany), according to the manufacturer’s instructions. 
If the GenElute™ kit was used, the DNAse I kit was used 
prior to cDNA synthesis. mRNA with concentrations 
between 0.5 and 1.0 µg/µL were used for the synthesis of 
cDNA using the High Capacity cDNA Reverse Transcrip-
tion kit (4368814, Thermo Fischer Scientific), according 
to the manufacturer’s instructions. The reverse transcrip-
tion was accomplished by a PTC-200 Thermal Cycler (MJ 
Research, Quebec, Canada). The synthesized cDNA was 
stored at − 20 °C until further use.
Real‑time quantitative polymerase chain reaction (qPCR)
The qPCR analysis was performed using a  Lightcycler® 
96 instrument and the FastStart DNA Master SYBR 
Green I mixture (Roche, Basel, Switzerland) with Riboloc 
R1 (Thermo Scientific) as RNAse inhibitor. A mixture 
of cDNA, primers (in a final concentration of 1  µM of 
forward and reverse primers), Water (PCR-grade) and 
master mix was used. Primer design was performed 
using SDSC Biology Workbench and NCBI and all prim-
ers were obtained from Thermo Fischer Scientific. The 
primer specifications are listed in Table  1. A total of 45 
cycles were performed after a pre-incubation of 600  s 
at 95 °C; each cycle contained a period of 95 °C for 10 s, 
55  °C for 10 s and 72  °C for 20 s, followed by a melting 
curve determination. Primer efficiencies were deter-
mined in-house by finding the slope of a ten-fold serial 
dilution calibration curve. Primer efficiencies were then 
calculated using the equation E = 10(−1/Slope) [31]. The 
selected primers had efficiencies between 1.9 and 2.1 
and melting curves displaying a single product. Selected 
genes included tight junction proteins Occludin (OCLN), 
Junction adhesion molecule 1 (F11R), Zonula occludens 
1 (TJP1), Claudin-1 (CLDN1) and -5 (CLDN5), efflux 
transporters P-glycoprotein (ABCB1), Breast cancer 
resistance protein (ABCG2), Multidrug resistance pro-
tein 1 (ABCC1) and -4 (ABCC4), SLC transporters LAT-1 
(SLC7A5), GLUT-1 (SLC2A1) and MCT-1 (SLC16A1), as 
well as the enzyme Alkaline phosphatase (ALP), Tissue 
plasminogen activator (TPA) and von Willebrand factor 
(VWF). A set of three reference genes (HPRT-1, GAPDH 
and β-actin) was used to normalize the mRNA expres-
sion levels of the genes of interest (see Additional file 1: 
Figs. S1 and S2 for Ct-values).
Data treatment and statistics
To convert quantification cycle values (Cq) into nor-
malized relative quantities, we used the  2−ΔΔCq method 
proposed by Livak & Schmittgen [24], but corrected for 
the estimated efficiency (E):  E−ΔCq [14, 28]. The ratio 
between the efficiency corrected mRNA expression of 
the reference genes and the gene of interest were then 
determined. Statistical tests in this study were performed 
using GraphPad Prism software (version 7). Data are 
shown as mean + standard error of the mean (SEM). All 
experiments were performed in at least three individual 
passages (n denotes number of passages) originating 
from different animals, and three technical replicates 
within each passage (N denotes the number of techni-
cal replicates), unless otherwise stated. Groups were 
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compared using an ANOVA test (one way), followed by a 
Tukey post test. P < 0.05 was considered significant.
For Fig.  5, data on human and murine brain capil-
lary endothelial cells were derived from two transcrip-
tomic databases developed by Betsholtz lab [13, 34] 
and Barres lab [37, 38], respectively. Data were derived 
as mean expression levels from the respective data-
base, and the mean expression levels were normalized 
against the corresponding expression levels of HPRT-1, 
GAPDH and β-actin reported in databases. In addition, 
the quantitative expression levels of tight junctions and 
efflux transporters found in the fresh bovine brain cap-
illaries and in endothelial cells cultured in co-contact 
configuration (plotted in Figs.  2 and 3) were replot-
ted as mean values alongside with data from the tran-
scriptomic databases for a rough visual comparison. 
Data from the databases were derived as mean values. 
The data reported in Betsholtz’ database were gener-
ated from two mice (Cldn5-GFP;Cspg4-DsRed geno-
type) [13, 34]. The murine and human data derived 
from Barres’ database are from two biological replicates 
Table 1 Overview of the investigated genes of interest as well as the used reference genes, their gene symbol, name and 
primers
The primer sequence, PCR efficiency and product size are listed for each of the designed primer sets
PCR Polymerase chain reaction, Bp base pairs, F forward, R reverse
Gene symbol Gene name PCR efficiency Product size 
(Bp)
Primer sequence (5′ to 3′)
HPRT1 Hypoxanthine guanine phosphoribosyl transferase 1 2.03 144 F: CGT GGT GAT TAG CGA TGA TG
R: TTC ATC ACA TCT CGA GCC AG
ACTB β-actin 1.91 426 F: AGG CTG TGC TGT CCC TGT AT
R: AGG TAG TTT CGT GAA TGC CG
GAPDH Glyceraldeyde-3-phosphate dehydrogenase 1.93 102 F: CGA CCA CTT TGT CAA GCT CA
R: GGA CCT TAC TCC TTG GAG GC
VWF von Willebrand Factor 1.92 126 F: TCT CAC GAG ACT GCA ACA CC
R: TGA AGT GCC TGT CGT CAA AG
ALP Alkaline phosphatase 1.98 139 F: ATC GGT ACC TGT TTT GCC AG
R: TGA TGA CGT TCT TAG CCA CG
TPA Tissue plasminogen activator 1.96 103 F: TCT TCT CCG TTC TTT TCC GA
R: TGT TGG TGA CGG TCC TGT TA
CLDN1 Claudin-1 2.06 122 F: CCG TTG GCA TGA AGT GTA TG
R: CCA TGC TGT GGC AAC TAA AA
CLDN5 Claudin-5 2.06 122 F: CAG AAG TAC GAG CTG GGA GC
R: TAC TTC ACC GGG AAG CTG AA
OCLN Occludin 2.05 143 F: CCG GAA GAT GAA ATT CTC CA
R: GTT CCA TAG CCT CTG TCC CA
TJP1 Zonula occludens 1
(Zo-1)
2.08 148 F: CGA CCA GAT CCT CAG GGT AA
R: GGA TTC TAC GAT GCG ACG AT
F11R Junctional adhesion molecule 1
(JAM-1)
1.94 113 F: TGC TGA CCT GCT CAG AGA GA
R: GGA AGA GTT GCT GAA GGC AC
ABCB1 P-glycoprotein
(Pgp)
1.99 127 F: CGG GAC AGA AAG CTC AGT TC
R: TAA TGG CGC AAA ATA CAC CA
ABCG2 Breast cancer resistance protein
(BCRP)
2.08 139 F: CCA GGC GTT CAT TCA AAA AT
R: GCT CTG TTC TGG ATT CCT GC
ABCC1 Multidrug resistance protein 1
(MRP-1)
2.03 106 F: GTT CCC CTC AAT GCT GTG AT
R: TCC CGT TGA GAA TTT CGT TC
ABCC4 Multidrug resistance protein 4
(MRP-4)
1.95 124 F: ATT AAA CGC CTG GAA TGT GC
R: GTG CAT TGA ACA GCT CCT GA
SLC2A1 Glucose transporter 1
(GLUT-1)
1.92 139 F: TAC CCC AAG AGG TGG CTA TG
R: CTG GTC TCA GGC AAG GAA AG
SLC7A5 L-type amino acid transporter 1
(LAT-1)
1.91 111 F: TAG CCA ATC TGG ATC CCA AG
R: TCA AGT AAT TCC ATC CCC CA
SLC16A1 Monocarboxylate transporter 1
(MCT-1)
1.91 143 F: TTT ACG CCT TTG ATT CCC AG
R: TCC CTA TTG GTT TCT GTG GG
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of Tie2–EGFP transgenic mice (n = 2) and from two 
patients (n = 2), respectively [37, 38].
Results
The present study aimed to elucidate to what extent 
downregulation of mRNA expression of important BBB 
endothelial genes occurred during culture of in vitro BBB 
models. Furthermore, it was investigated to what degree 
co-culture with astrocytes could “rescue” the BBB phe-
notype in cultured brain capillary endothelial cells, i.e. 
increase transcript levels which were downregulated 
in vitro in mono cultures. In vitro mRNA transcript lev-
els were measured in three different culture configura-
tions, monoculture (MC), non-contact co-culture (NCC) 
and contact co-culture (CCC) (schematic drawing in 
Fig.  1a) and compared with the mRNA levels in freshly 
isolated intact brain capillaries.
The brain endothelial markers von Willebrand factor 
and alkaline phosphatase were highly expressed 
in cultured endothelial cells
The mRNA expressions level of three typical brain 
endothelium markers, von Willebrand factor (VWF), 
Alkaline phosphatase (ALP) and Tissue plasminogen 
activator (TPA) were investigated. The in vitro cultures 
of bovine brain capillary endothelial cells in mono cul-
ture and co-culture with astrocytes were compared 
to that estimated in intact brain capillaries. VWF was 
found to be highly expressed in all in vitro model con-
figurations, and significantly higher mRNA expression 
levels were observed in endothelial cells co-cultured 
with astrocytes, as compared to the expression level 
in intact brain capillaries (Fig. 1b). The mRNA expres-
sion level of VWF in MC showed a clear tendency to 
increase as compared to intact capillaries, but statis-
tically non-significant. Contrary to VWF, the mRNA 
expression levels of ALP did not differ significantly 
between the different culture conditions and brain 
capillaries. However, a tendency of mRNA expression 
Fig. 1 BBB markers. a Schematic drawing of the different in vitro culture configurations. Bovine capillary endothelial cells were seeded on the 
apical side of the filter in all culture configurations. In non-contact co-culture, the rat astrocytes were seeded in the bottom of the well, whereas 
they were seeded on the basolateral side of the filter in the contact co-culture. b Quantitative analysis of the mRNA expression levels of VWF. The 
expression of VWF were significantly higher in NCC and CCC compared to capillaries. c Quantitative analysis of the mRNA expression levels of ALP. 
There were no significant difference in the expression levels. d Quantitative analysis of the mRNA expression levels of TPA. All culture configurations 
were significantly downregulated compared to capillaries. MC mono culture, NCC non-contact co-culture and CCC contact co-culture, vWF von 
Willebrand Factor, ALP alkaline phosphatase, TPA tissue plasminogen activator. n = 5 − 3, N = 3. **: P ≤ 0.005. Error bars are Mean + SEM
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elevation was observed in CCC compared to expres-
sion levels estimated in MC, NCC and intact brain 
capillaries, indicating that the presence of astrocytes 
influenced induced the mRNA expression levels of ALP 
(Fig.  1c). For TPA, on the other hand, we observed a 
significantly lower expression level in all culture config-
urations as compared to the expression level estimated 
in bovine brain capillaries (Fig. 1d).
mRNA levels of tight junction‑associated proteins 
claudin‑5, claudin‑1, zo‑1 and JAM1 were not changed 
by culture, whereas occludin transcript levels decreased
Tight junction proteins (TJs) are highly expressed in 
the brain capillary endothelial cells resulting in an 
extremely tight and polarized barrier that selectively 
controls trafficking of molecules between the blood and 
CNS. TJs are complex structures that rapidly undergo 
alterations in expression levels. We measured the tran-
script levels of the brain endothelial TJ proteins Clau-
din-1 and -5, Occludin and Zo-1 (CLDN1, CLDN5, 
OCLN and TJP1) and the junctional adhesion molecule 
1, JAM-1, (F11R) in brain capillary endothelial cells to 
see whether TJ complex transcripts were downregu-
lated by in  vitro culture, and whether the expression 
levels could be increased by co-culture with astrocytes. 
The transcript levels of CLDN5 were similar in capillar-
ies, MC, NCC and CCC (Fig. 2d). TJP1 and F11R tran-
script levels showed a similar pattern (Fig. 2a, b). These 
results indicated that transcript levels of these genes 
were unaffected by in  vitro culture or the presence of 
astrocytes. The expression level of OCLN was found to 
be significantly downregulated in endothelial cells cul-
tured in MC and NCC, as compared to the level esti-
mated in intact brain capillaries. Expression levels of 
OCLN in CCC were increased as compared to MC and 
NCC and was not significantly different from expres-
sion levels in capillaries (Fig.  2c). CLDN1 transcript 
levels were low in capillaries and in all culture config-
urations (Fig.  2e) and no significant differences were 
observed, indicating absence of CLDN1 from capillary 
endothelial cells, both in vivo and in vitro. The transen-
dothelial electrical resistance (TEER) of the different 
Fig. 2 Tight junction proteins. a Quantitative mRNA expression levels of F11R. There were no significant differences in expression levels. b 
Quantitative mRNA expression levels of TJP1. There were no specific differences in expression levels. c Quantitative mRNA expression levels of OCLN. 
OCLN was significantly downregulated in MC and NCC compared to capillaries. d Quantitative mRNA expression levels of CLDN5. There were no 
significant differences in expression levels. e Quantitative expression levels of CLDN1. CLDN1 expression levels were low in all culture configurations. 
n = 3, N = 3. F: Trans-endothelial electrical resistance (TEER) in the different models, n = 4 − 6, N = 4 − 17. Please note that the y-axis are different 
in all graphs. F11R: JAM-1, TJP1: Zo-1, OCLN: Occludin, CLDN5: Claudin-5, CLDN1: Claudin-1, MC: Mono culture, NCC: Non-contact co-culture, CCC: 
Contact co-culture. *: P ≤ 0.05, **: P ≤ 0.005. Error bars are mean + SEM
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culture configurations was measured to ensure barrier 
integrity (Fig.  2f ). The cell monolayers exhibited high 
barrier tightness, with TEER at 632 (118) Ω∙cm2, 977 
(278) Ω∙cm2 and 1410 (506) Ω∙cm2 for MC, NCC and 
CCC, respectively (Fig. 2f ).
ABC‑type efflux pumps ABCB1, ABCG2, ABCC1 and ABCC4 
responded differentially to culture
Efflux transporters at the BBB represent a major obstacle 
in drug discovery and development, as many novel small 
drug candidates developed for brain diseases cannot 
cross the BBB due to active efflux. We evaluated to what 
degree the transcript levels of P-glycoprotein (ABCB1), 
Breast-cancer resistance related protein BCRP (ABCG2), 
Multidrug-resistance related protein 1, MRP1 (ABCC1) 
and Multidrug-resistance related protein 4, MRP4, 
(ABCC4) were altered in the cell cultures. We found 
that the expression level of ABCB1 was significantly 
downregulated in all in  vitro culture configurations as 
compared to the expression levels found in brain capil-
laries. Co-culture with astrocytes showed a tendency 
to increase the expression level of ABCB1 in bovine 
brain endothelial cells (Fig. 3a). ABCG2 exhibited a ten-
dency to decrease in the culture models as compared 
to the expression level in brain capillaries (Fig.  3b). We 
observed a significant increase in the expression levels 
of ABCC1 in cultures as compared to capillaries. CCCs 
furthermore displayed higher expression levels than 
MCs (Fig. 3c). The level of ABCC4 showed a tendency to 
increase in culture (Fig. 4d). Comparisons of the absolute 
expression levels showed that ABCB1 and ABCG2 were 
higher in all culture configurations and in brain capillar-
ies, as compared to ABCC1 and ABCC4.
Fig. 3 Efflux transporters. a Quantitative mRNA expression levels of ABCB1. The expression levels were significantly decreased from capillaries to 
all culture configurations. b Quantitative mRNA expression levels of ABCG2. There were no significant differences in expression levels of ABCG2. c 
Quantitative mRNA expression levels of ABCC1. The expression of ABCC1 was significantly increased from capillaries to all culture configurations. 
There was a significant increase in the expression in CCC compared to MC. d mRNA expression levels of ABCC4. There were no significant differences 
in expression levels, although a non-specific increase was observed from capillaries to all culture configurations. ABCB1: Pgp, ABCG2: BCRP, ABCC1: 
MRP-1, ABCC4: MRP-4. MC: Mono culture, NCC: Non-contact co-culture, CCC: Contact co-culture. n = 3, N = 3. *: P ≤ 0.5. Error bars are mean + SEM
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SLC transporter transcript levels of LAT‑1, GLUT‑1 
and MCT‑1 were markedly lower in cultured endothelial 
cells, as compared to capillaries
Finally, we evaluated the expression levels of three key 
SLC transporters at the BBB, namely glucose transporter 
1, GLUT-1, (SLC2A1), large neutral amino acid trans-
porter 1, LAT-1, (SLC7A5) and monocarboxylate trans-
porter 1, MCT1, (SLC16A1). A significant decrease in 
expression levels of SLC2A1, SLC16A1 and SLC7A5 was 
observed in the cell cultures compared to mRNA levels 
in brain capillaries (Fig.  4). The presence of astrocytes 
did not seem to affect the expression levels of SLC2A1 or 
SLC16A1. For SLC7A5, we observed a non-significantly 
increase in the expression level in NCC and CCC com-
pared to MC; although it was still significantly lower than 
the expression level in brain capillaries (Fig. 4c).
Discussion
In vitro models of the BBB must recapitulate many 
attributes of the native BBB by forming monolayers with 
restrictive barrier properties and expressing key proteins, 
such as TJs, SLC transporters and ABC transporters. Pre-
vious studies have shown that in  vitro culture of brain 
capillary endothelial cells may alter the expression lev-
els of important BBB markers and transporters as com-
pared to the expression level in the native brain capillary 
endothelium [5, 9, 18, 19]. This can have implications for 
the translational value of data obtained in in vitro experi-
ments when correlating in vitro data to in vivo situations. 
We therefore aimed at examining the transcript levels 
of some key genes, known to be highly expressed in the 
native brain capillary endothelium, in in  vitro cultures 
of brain capillary endothelial cells derived from bovine 
brains. The endothelial cells were cultured in MC, NCC 
and CCC configurations with rat astrocytes to examine 
whether astrocytes could rescue the phenotypic BBB fea-
tures in the endothelial cells. Rat astrocytes in in  vitro 
cultures of bovine endothelial cells are widely use due to 
the ability of rat astrocytes to proliferate for an extended 
culture period (see review: [15], and has been shown to 
induce several phenotypic BBB traits in bovine capillary 
endothelial cells [2, 11].
In the present study, we observed that expression of 
several important BBB genes was altered in the in  vitro 
cultures of primary bovine brain endothelial cells as 
compared to brain capillaries. VWF, a widely used brain 
endothelial marker, was found to be higher expressed in 
the in  vitro cultures than brain capillaries. A previous 
study has shown that VWF exhibits a protective role in 
pathological conditions, such as seizures, hypoxia and 
spontaneous intracerebral hemorrhage by promoting and 
modulating BBB flexibility and opening during disease 
states [32]. This protective role of VWF indicates that the 
increased mRNA expression level of VWF observed in 
the in vitro models is presumably due to an in vitro arti-
fact, resulting from adaptation of the endothelial cells to 
the ambient conditions during in  vitro culture. In addi-
tion, the expression level of VWF was slightly increased 
in co-culture with rat astrocytes as compared to MC. 
Several studies have shown that astrocytes in both CCC 
and NCC have proven efficient in inducing general BBB 
phenotypic traits in brain capillary endothelial cells [16]. 
This was also reflected in TEER measurements, where 
endothelial cells cultured in  vitro showed the ability to 
form a barrier with high functional tightness, and co-cul-
ture with astrocytes led to an improved barrier tightness 
compared to MC. The transcript levels of genes involved 
in TJ formation were unaltered in the in vitro cultures as 
Fig. 4 SLC-transporters. a mRNA expression level of SLC2A1. SLC2A1 was significantly downregulated in all culture configurations compared 
to capillaries. b mRNA expression level of SLC16A1. A significant decrease was observed from capillaries to all culture configurations. c mRNA 
expression levels of SLC7A5. SLC7A5 was significantly downregulated from capillaries to all culture configurations. SLC2A1: GLUT1, SLC16A1: MCT-1, 
SLC7A5: LAT1. MC: Mono culture, NCC: Non-contact co-culture, CCC: Contact co-culture. n = 3, N = 3. **: P ≤ 0.05, ****: P ≤ 0.0005. Error bars are 
mean + SEM
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compared to those estimated in brain capillaries, except 
for OCLN. The brain capillary endothelial cells were thus 
still able to form tight monolayers, even though OCLN 
was found to be downregulated in the in vitro cultures. 
Saitou et  al. [29] have previously shown that OCLN is 
not required for the formation intact TJs in epithelial 
cells derived from embryonic stem cells lacking OCLN. 
Similarly, they later found that mice lacking OCLN could 
still form intact TJs [30]. However, the mice underwent 
complex abnormalities, such as calcification around brain 
vessels, indicating another physiological role of OCLN in 
addition to TJ formation. In a recent study, Berndt et al. 
[3] showed a loss of TJ complexity in in  vitro models 
compared to in vivo capillaries from human and mouse. 
They found that other not commonly investigated CLDN 
genes were abundantly present in  vivo (CLDN11, -12, 
-25 and -27) but almost depleted in  vitro. The authors 
hypothesized that in  vitro cultures tend to overexpress 
CLDN5. We did, however, observe unaltered expression 
levels of CLDN5 and CLDN1 in the in vitro cultures and 
in bovine brain capillaries, recapitulating the in vivo situ-
ations. We observed a low baseline expression of CLDN1 
in cultured endothelial cells and capillaries as compared 
to the expression level of CLDN5, OCLN, TJP1 and F11R. 
This was in agreement with previous transcriptomic 
studies on human and murine brain capillary endothelial 
cells [13, 34, 37, 38], which similarly demonstrated that 
CLDN1 was low expressed, while OCLN, CLDN5, TJP1 
and F11R were highly abundant in murine and human 
brain capillary endothelial cells (Fig. 5a). This suggests no 
or negligible involvement of CLDN1 in tightening of the 
BBB. This correlates with previous studies that report an 
intracellular localization of CLDN1 rather than localiza-
tion at the junctional zones [3, 27]. The expression level 
of ABCB1 was found to be significantly downregulated, 
while ABCC1 and ABCC4 expression levels were 
increased in the cell culture models. Earlier mRNA 
transcript studies on bovine endothelial cells have also 
demonstrated a lower expression of a number of ABC 
transporters (ABCG1, ABCA1, ABC2, ABCA3, ABCA7) 
in cultures, as compared to capillaries [12].
Helms et  al. [17] have previously found that P-gp, 
BCRP and at least one isoform of MRPs are expressed 
and functionally active in the bovine capillary endothe-
lial cells co-cultured with rat astrocytes. Previous studies 
have shown that functional MRP1 is lacking at the BBB 
in mice [7, 36]. Another study shows that the protein 
expression level of ABCC1 is under the limit of detection 
at the porcine BBB [39]. Comparing the data obtained 
in this study with previous transcriptomic studies on 
human and murine brain capillary endothelial cells, both 
ABCB1 and ABCG2 are the most dominant members of 
ABC-transporter coding genes with expression levels 
being markedly greater than ABCC1 and ABCC4 across 
the species (Fig. 5b).
Taken together, the increases in mRNA levels of 
ABCC1 and ABCC4 are likely due to an in vitro artifact. 
A similar observation has been reported by Berezowski 
et al. [2] who showed that MRP1 transcript was present 
in culture but not in intact bovine capillaries. Another 
reason for the increase of ABCC1, that we observe, may 
be the use of dexamethasone in culture medium that 
previously has been reported to induce the expression 
of functional ABC-transporters in endothelial cells [2, 
12]. These findings highlight the difficulty in finding 
suitable growth factors for enhancing the BBB pheno-
type in vitro, as the benefits in some cases can lead to 
in  vitro culture artifacts in others, as observed with 
ABCC1. This was also observed in the expression lev-
els of ALP between the different culture configurations. 
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Fig. 5 Comparison of TJ and ABC gene expression levels across different species. a mRNA expression levels of OCLN, CLDN1, CLDN5, TJP1 and F11R, 
and b mRNA expression levels of ABCB1, ABCC1, ABCC4 and ABCG2 in murine, human and bovine brain capillary endothelial cells and in endothelial 
cells cultured in contact co-culture (CCC) configuration with astrocytes. Transcriptomic data for murine brain capillary endothelial cells (mcapEC) 
is derived from transcriptomic databases from the Betsholtz lab (Bz) (http://betsh oltzl ab.org/Vascu larSi ngleC ells/datab ase.html) and the Barres lab 
(http://www.brain rnase q.org/). Data for human brain capillary endothelial cells (hcapEC) are from the Barres lab et al. (Br). All data were normalized 
against endothelial HPRT-1, GAPDH and β-actin expression in the relative databases. Data are shown as mean values. Human data from Barres 
database: n = 2. Murine data from Barres database: n = 2. Murine data from Betsholtz database: n = 2. Bovine data: n = 3, N = 3
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A previous study proposed that direct contact between 
endothelial cells and astrocytes are necessary to main-
tain a high expression of ALP in in vitro cultures [26]. 
However, we observed that cultured endothelial cells 
could maintain a high baseline expression level of ALP, 
independent of the culture configurations. The con-
trasting results suggest that the effects of astrocytes 
on ALP may be lacking due to the presence of cAMP 
in differentiation media during culture, which similarly 
to astrocytes has been shown to induce ALP in primary 
porcine brain endothelial cultures [4]. Thus, cAMP may 
cause the high baseline expression of ALP in the cell 
culture models. In addition to ABCB1, the transcript 
levels of SLC2A1, SLC16A1 and SLC7A5 were markedly 
downregulated by in  vitro culture. The downregula-
tion of SLC transporters is a general issue in primary 
cultures of brain endothelial cells [15]. Calabria et  al. 
[5] have previously shown that in  vitro culture of pri-
mary rat endothelial cells resulted in a downregulation 
of SLC transporters such as Slc2a1 and Slco1c1 and 
we have previously shown a similar downregulation 
of the mRNA expression levels of the insulin recep-
tor and transferrin receptor from capillaries to bovine 
in  vitro models [18, 19]. This possible de-differenti-
ation may pose a challenge for investigations on drug 
delivery routes involving transporters or receptors 
that are downregulated in in vitro models. Overall, we 
thus observed that for the SLCs there was a significant 
downregulation in cultures as compared to capillaries, 
which could not be rescued by astrocyte co-culture. It 
has, however, been shown that bovine pericytes may 
cause BBB induction  as well [33], and we can there-
fore not exclude that presence of more cell types could 
increase SLC expression.
It should be noted that the capillary fraction here still 
contains astrocyte remnants, as previously shown [19]. 
This may lead to an overestimation of the level of SLC-
transporters, which are also present in astrocytes. The 
findings in the present study emphasize the relevance of 
investigating expression levels of essential transporters 
in the BBB. Even though the expression levels were low 
in our model, it would be very interesting to investigate 
whether the transporters are active, yielding a poten-
tial novel model for investigations of SLC transporters 
as a drug delivery system. The differences between the 
mRNA expression in capillaries and our models may 
largely be a consequence of the environment in  vitro 
that tries to mimic the BBB in  vivo. The crude imita-
tion of the microenvironment in vivo, the lack of con-
tact to other cell types, such as pericytes, microglia 
and neurons, as well as lack of shear stress from blood 
flow, contributes largely to the differences in in  vitro 
culture (as reviewed by [25]). In fact, the exposure of 
cells to laminar shear stress is often missing in many 
in vitro BBB models. Incorporation of shear stress into 
the culture protocol of in vitro BBB models has previ-
ously been shown to promote BBB tightness and to 
upregulate the transcript levels of efflux transporters 
and several SLC transporters as compared to the static 
models [8, 10]. Thus, introducing laminar shear stress 
to the culture protocol could be another approach for 
enhancing the phenotypic BBB traits in the in vitro BBB 
models.
The brain and the NVU are both complex systems to 
study and are therefore impossible to replicate in  vitro, 
which makes it important to remember possible biases 
when using in vitro models. Furthermore, it is a field that 
largely uses primary cells, which are extremely sensitive 
to changes and the artificial conditions the in vitro mod-
els undergo during culture, as shown in the present study. 
Still, in vitro models are a vital tool in the investigation 
of potential drug delivery routes across the BBB. Co-cul-
ture with primary rat astrocytes had an inducing effect 
on the mRNA expression levels of some genes, although 
the overall impact on the model was minor. It is impor-
tant to remember though, that to validate our results, 
protein localization and expression studies would ben-
efit this study and highlight the importance of co-culture 
further. This study showed gene expression alterations of 
several important transporters in in vitro models of the 
BBB using primary bovine endothelial cells. It is there-
fore necessary to thoroughly characterize in  vitro mod-
els before studying potential drug transport routes across 
the BBB, as to be aware of the possibility of lower expres-
sion of BBB transporters due to culture.
Conclusion
We investigated differences in mRNA expression levels 
of selected marker proteins in brain capillaries and brain 
endothelial in vitro cultures. The present study confirms 
that the bovine endothelial cell/rat astrocyte co-culture 
models undergo a phenotypic alteration as compared to 
endothelial cells in intact brain capillaries. Mono-, non-
contact- and contact co-cultures overall retained mRNA 
expression of junction-associated proteins. OCLN, how-
ever, was decreased on mRNA expression levels in vitro. 
The mRNA expression of the SLC transporters SLC2A1, 
SLC16A1 and SLC7A5 were markedly downregulated, 
and co-culture with astrocytes did not “rescue” the 
expression levels. Efflux transporters ABCB1 and ABCG2 
were downregulated while ABCC1 and ABCC4 were 
upregulated compared to in vivo.
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At present, no in  vitro model of the BBB mimics the 
native brain capillary endothelium fully. The bovine co-
culture in  vitro models retain barrier properties and 
efflux transporter activity but have a suboptimal expres-
sion of important SLC transporters which must be con-
sidered when investigating trans-endothelial nutrient 
transport and SLC mediated drug delivery.
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